PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Research & Development: Rp0 Mil (TTM As of Mar. 2026)


ISX:SIDO PT Industri Jamu dan Farmasi Sido Muncul Tbk ISX:SIDO
86 GF Score
Price Rp372.00
GF Value Rp604.44
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is PT Industri Jamu dan Farmasi Sido Muncul Tbk Research & Development?

PT Industri Jamu dan Farmasi Sido Muncul Tbk ISX:SIDO -1.59% 86 Research & Development is Rp0 Mil as of Mar. 2026. GuruFocus rates ISX:SIDO with a GF Score™ of 86/100 and a GF Value™ of Rp604.44 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT Industri Jamu dan Farmasi Sido Muncul Tbk's Research & Development for the three months ended in Mar. 2026 was Rp0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was Rp0 Mil.

PT Industri Jamu dan Farmasi Sido Muncul Tbk  (ISX:SIDO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Industri Jamu dan Farmasi Sido Muncul Tbk Research & Development Related Terms

PT Industri Jamu dan Farmasi Sido Muncul Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Industri Jamu dan Farmasi Sido Muncul Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Industri Jamu dan Farmasi Sido Muncul Tbk Research & Development Chart

PT Industri Jamu dan Farmasi Sido Muncul Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PT Industri Jamu dan Farmasi Sido Muncul Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ISX:SIDO
86GF Score
PT Industri Jamu dan Farmasi Sido Muncul Tbk ISX:SIDO
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Industri Jamu dan Farmasi Sido Muncul Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp0 Mil mean?
PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) has a Research & Development of Rp0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on PT Industri Jamu dan Farmasi Sido Muncul Tbk and its competitors.
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk's Research & Development too high?
PT Industri Jamu dan Farmasi Sido Muncul Tbk's current Research & Development is Rp0 Mil. Overall, PT Industri Jamu dan Farmasi Sido Muncul Tbk has a GF Score™ of 86/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Industri Jamu dan Farmasi Sido Muncul Tbk's Research & Development compare to KHC and GIS?
PT Industri Jamu dan Farmasi Sido Muncul Tbk's Research & Development of Rp0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Industri Jamu dan Farmasi Sido Muncul Tbk and its competitors. PT Industri Jamu dan Farmasi Sido Muncul Tbk's current Research & Development is Rp0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp604.44, compared to a current price of Rp372.00 — trading 38.5% below its estimated fair value. The current Research & Development is Rp0 Mil. PT Industri Jamu dan Farmasi Sido Muncul Tbk's overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO), the current Research & Development is Rp0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Overvalued in 2026?

Based on GuruFocus' analysis, PT Industri Jamu dan Farmasi Sido Muncul Tbk stock appears to be undervalued. The current stock price of Rp372.00 is trading 38.5% below its estimated GF Value™ of Rp604.44. GuruFocus considers PT Industri Jamu dan Farmasi Sido Muncul Tbk to be Significantly Undervalued.

Key valuation signals for ISX:SIDO:

  • Research & Development: Rp0 Mil
  • GF Value™: Rp604.44 vs. price of Rp372.00 (38.5% below fair value)
  • GF Score™: 86/100 with 1 warning sign

No single metric tells the full story. See the ISX:SIDO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Industri Jamu dan Farmasi Sido Muncul Tbk Business Description

Address Jalan Gajahmada No. 123, 1st Floor, Tentrem Hotel Building, Office Sido Muncul, Lantai 1, Pekunden Subdistrict, Semarang, IDN, 50134
PT Industri Jamu dan Farmasi Sido Muncul Tbk is focused on the herbal medicine and herbal products industry, with its products categorized into three distinct segments: Herbal Medicine and Supplements, Food and Beverages, and Pharmaceuticals. Its flagship herbal products include Tolak Angin, available in variants such as Tolak Angin Cair, Tolak Angin Cair Anak, Tolak Angin Sugar Free, Tolak Angin Batuk, and Tolak Angin Flu. The Herbal Medicine segment provides herbal supplements, while its Food and Beverage segment sells packaged foods, soft drinks, and candy and confectionery products. The Pharmacy segment sells pharmaceutical products, including Anacetine Syrup, Inflasone, Berlosid, Licokalk, and Licodexon. The majority of revenue is derived from the Herbal Medicine & Supplement segment.
86GF Score

Get the complete analysis for ISX:SIDO

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp372.00
Price
Rp604.44
GF Value